{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:38:06Z","timestamp":1792525086110,"version":"4.5.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191316","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T13:41:18Z","timestamp":1519393278000},"page":"e0191316","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes \u2013 A feasibility study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0311-1174","authenticated-orcid":true,"given":"Aslaug Johanne","family":"Ris\u00f8y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reidun Lisbet Skeide","family":"Kjome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una \u00d8rvim","family":"S\u00f8lvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"ref1","article-title":"Diabetes in Norway\u2014Public Health Report","author":"LC Stene","year":"2014"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e0171152","DOI":"10.1371\/journal.pone.0171152","article-title":"Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study","volume":"12","author":"B Kowall","year":"2017","journal-title":"PloS one"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc13-2101","article-title":"Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence","volume":"37","author":"M Porta","year":"2014","journal-title":"Diabetes care"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"WH Herman","year":"2015","journal-title":"Diabetes care"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.18.2.258","article-title":"Hyperglycemia and microvascular and macrovascular disease in diabetes","volume":"18","author":"R Klein","year":"1995","journal-title":"Diabetes care"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00125-011-2441-9","article-title":"How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort","volume":"55","author":"M Rahman","year":"2012","journal-title":"Diabetologia"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-148-11-200806030-00008","article-title":"Screening adults for type 2 diabetes: a review of the evidence for the US Preventive Services Task Force","volume":"148","author":"SL Norris","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"ref8","first-page":"326","article-title":"Cost effectiveness of type 2 diabetes screening: A systematic review","volume":"30","author":"B Najafi","year":"2016","journal-title":"Medical journal of the Islamic Republic of Iran"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/1471-2458-11-603","article-title":"Emotional impact of screening: a systematic review and meta-analysis","volume":"11","author":"RE Collins","year":"2011","journal-title":"BMC public health"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876524601306010001","article-title":"Screening for Type 2 Diabetes in Adults: An Updated Systematic Review","volume":"6","author":"D Sherifali","year":"2013","journal-title":"Open Diabetes J"},{"key":"ref11","article-title":"Screening for Type 2 Diabetes","year":"2003"},{"issue":"Suppl 1","key":"ref12","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","year":"2010","journal-title":"Diabetes care"},{"key":"ref13","unstructured":"HealthKnowledge. Diffrences between screening and- diagnostic tests, case finding HealthKnowledge: Public Health Action Support Team (PHAST) 2011 [cited 2017 01.03]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.healthknowledge.org.uk\/public-health-textbook\/disease-causation-diagnostic\/2c-diagnosis-screening\/screening-diagnostic-case-finding\" xlink:type=\"simple\">https:\/\/www.healthknowledge.org.uk\/public-health-textbook\/disease-causation-diagnostic\/2c-diagnosis-screening\/screening-diagnostic-case-finding<\/ext-link>."},{"key":"ref14","unstructured":"Helsedirektoraret. Nasjonal faglig retningslinje for diabetes Helsedirektoratet.no: Helsedirektoratet; 2016 [cited 2017 05.02]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/helsedirektoratet.no\/retningslinjer\/diabetes\/seksjon?Tittel=diagnostikk-av-diabetes-risikovurdering-2679-risikovurdering-og-p\u00e5visning-av-diabetes\" xlink:type=\"simple\">https:\/\/helsedirektoratet.no\/retningslinjer\/diabetes\/seksjon?Tittel=diagnostikk-av-diabetes-risikovurdering-2679-risikovurdering-og-p\u00e5visning-av-diabetes<\/ext-link>."},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"J Lindstrom","year":"2003","journal-title":"Diabetes care"},{"issue":"Suppl 1","key":"ref16","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes care"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"IE Committee","year":"2009","journal-title":"Diabetes care"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1464-5491.2010.03037.x","article-title":"The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting","volume":"27","author":"LJ Gray","year":"2010","journal-title":"Diabet Med"},{"key":"ref19","unstructured":"Diabetesforbundet, Helsedirektoraret. Sjekk din diabetesrisiko: Diabetesforbundet Helsedirektoratet 2015 [cited 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/diabetes.no\/risikotest-western-background-info\" xlink:type=\"simple\">https:\/\/diabetes.no\/risikotest-western-background-info<\/ext-link>."},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2524.2000.00222.x","article-title":"Community pharmacy as a primary health and self-care resource: a framework for understanding pharmacy utilization","volume":"8","author":"K Hassell","year":"2000","journal-title":"Health & social care in the community"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4321\/S1886-36552008000200003","article-title":"Health information, an area for competition in Swedish pharmacies","volume":"6","author":"EC Larsson","year":"2008","journal-title":"Pharmacy practice"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e91157","DOI":"10.1371\/journal.pone.0091157","article-title":"The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting","volume":"9","author":"A Willis","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3821\/145.4.cpj165","article-title":"HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes","volume":"145","author":"J Papastergiou","year":"2012","journal-title":"Canadian pharmacists journal: CPJ = Revue des pharmaciens du Canada: RPC"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.diabres.2015.03.006","article-title":"Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study","volume":"108","author":"N Fikri-Benbrahim","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ijpp.12228","article-title":"Community pharmacy-based A1c screening: a Canadian model for diabetes care","volume":"24","author":"J Papastergiou","year":"2016","journal-title":"The International journal of pharmacy practice"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijnurstu.2012.09.010","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"50","author":"P Craig","year":"2013","journal-title":"International journal of nursing studies"},{"key":"ref27","unstructured":"AS SH. DCA Vantage Analyzer Siemens Healthcare AS: Siemens Healthcare AS; 2017 [cited 2017 29.]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.healthcare.siemens.no\/point-of-care\/diabetes\/dca-vantage-analyzer\/technical-specifications\" xlink:type=\"simple\">https:\/\/www.healthcare.siemens.no\/point-of-care\/diabetes\/dca-vantage-analyzer\/technical-specifications<\/ext-link>."},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health policy (Amsterdam, Netherlands)"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medcli.2011.05.025","article-title":"Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study","volume":"138","author":"F Soriguer","year":"2012","journal-title":"Medicina cl\u00ednica"},{"issue":"Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc17-S005","article-title":"2. Classification and Diagnosis of Diabetes","volume":"40","author":"A American Diabetes","year":"2017","journal-title":"Diabetes care"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11096-006-9034-6","article-title":"Sequential screening for diabetes\u2014evaluation of a campaign in Swiss community pharmacies","volume":"28","author":"KE Hersberger","year":"2006","journal-title":"Pharmacy world & science: PWS"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.diabres.2006.06.022","article-title":"Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy","volume":"75","author":"I Krass","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"ref33","unstructured":"Apotekforeningen. 3.1 APOTEKKUNDER OG RESEPTEKSPEDISJONER apotekforeningen.no: Apotekforeningen; 2016 [cited 2017 26.05.17]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.apotek.no\/fakta-og-ressurser\/statistikk-(old)\/3\u2014apotekkunden\/3-1-apotekkunder-og-reseptekspedisjoner\" xlink:type=\"simple\">http:\/\/www.apotek.no\/fakta-og-ressurser\/statistikk-(old)\/3\u2014apotekkunden\/3-1-apotekkunder-og-reseptekspedisjoner<\/ext-link>."},{"issue":"7618","key":"ref34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bmj.39303.723449.55","article-title":"Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial","volume":"335","author":"HC Eborall","year":"2007","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1370\/afm.1737","article-title":"Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior","volume":"13","author":"JB Echouffo-Tcheugui","year":"2015","journal-title":"Annals of family medicine"},{"key":"ref36","article-title":"Evaluation of the Modified FINDRISC Diabetes Score to Identify Individuals at High Risk for Diabetes among Middle-aged White and Black ARIC Study Participants","author":"M Kulkarni","year":"2017","journal-title":"Diabetes, obesity & metabolism"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3346\/jkms.2012.27.3.255","article-title":"Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes","volume":"27","author":"WJ Lee","year":"2012","journal-title":"Journal of Korean medical science"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MLR.0b013e3181844855","article-title":"Using the EQ-5D Index Score as a Predictor of Outcomes in Patients With Type 2 Diabetes","volume":"47","author":"PM Clarke","year":"2009","journal-title":"Medical care"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.diabres.2016.08.010","article-title":"Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population","volume":"120","author":"G Stiglic","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0168-8510(91)90141-J","article-title":"EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway","volume":"18","author":"E Nord","year":"1991","journal-title":"Health policy (Amsterdam, Netherlands)"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1373\/clinchem.2013.210781","article-title":"Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices","volume":"59","author":"UO Solvik","year":"2013","journal-title":"Clin Chem"},{"key":"ref42","unstructured":"ISO. Point-of-care testing (POCT)\u2014Requirements for quality and competence. Geneva: 2006."},{"key":"ref43","article-title":"Quality management: approches to reducing errors at the point of care; approved gulideline","author":"P Waynes","year":"2010"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Y Wu","year":"2014","journal-title":"International journal of medical sciences"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2015.03.022","article-title":"Opportunistic Risk Screening for Type 2 Diabetes: Exploring of Application of Diabetes Risk Assessment Tool in Community Pharmacy in Australia and Thailand","volume":"9","author":"T Thoopputra","year":"2016","journal-title":"Value in health regional issues"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12913-015-1065-z","article-title":"Challenges in the provision of healthcare services for migrants: a systematic review through providers&apos; lens","volume":"15","author":"R Suphanchaimat","year":"2015","journal-title":"BMC health services research"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.socscimed.2010.04.010","article-title":"Somali immigrant women and the American health care system: discordant beliefs, divergent expectations, and silent worries","volume":"71","author":"CL Pavlish","year":"2010","journal-title":"Social science & medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:43:02Z","timestamp":1540341782000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191316"}},"subtitle":[],"editor":[{"given":"No\u00ebl C.","family":"Barengo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191316","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]}}}